Hepatitis C

HC Deb 22 March 2001 vol 365 cc355-6W

Ms Church

To ask the Secretary of State for Health how he plans to build on the strategic approach to hepatitis C. [1555401

Yvette Cooper

The Department of Health is setting up a steering group with the following terms of referenceTo oversee development of the Department's strategic approach to hepatitis C by bringing together issues relating to prevention, control and treatment and to produce a document within the year, for consultation with the NHS, professional bodies and the voluntary and community sectors.

The proposed membership of the group is as follows:

Steering group membership

Chairman Professor Howard Thomas, Imperial College School of Medicine, London and Chairman, Advisory Group on Hepatitis

Members Jim Camp, Needle Exchange Forum Ms Hannah Cinamon, Health Promotion England Professor Chris Day, Medical School, Newcastle University Ms Jo Guy, Hepatology Nurse Specialist, Southampton General Hospital Dr. Paul Hatton, Consultant in Communicable Disease Control, Leeds Health Authority and member. Advisory Group on Hepatitis

Ms Lorraine Hewitt,Action on Hepatitis C and member, Advisory Council on the Misuse of Drugs Nigel Hughes, British Liver Trust Dr. Will Irving, Department of Microbiology, University of Nottingham and member, Advisory Group on Hepatitis Grant McNally, National Drug Users Development Agency Dr. Mary Ramsay,[...] Public Health Laboratory Service Communicable Disease Surveillance Centre Professor Gerry Stimson, Centre for Research on Drugs and Medicine, Imperial College School of Medicine, London Professor John Strang, Director of the National Addiction Centre, Maudsley Hospital, London and member of the Advisory Council on the Misuse of Drugs Ms Monique Tomlinson, Mainliners Dr. Martyn Wake, General Practitioner, south west London.